{"id":"W2436980626","doi":"10.1007/s00415-016-8182-4","title":"Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Journal of Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"NeuroRx Research (Canada); McGill University; Montreal Neurological Institute and Hospital","funders":"Teva Pharmaceutical Industries; Biogen","keywords":"Multiple sclerosis; Relapsing remitting; Medicine; Neurology; Neuroradiology; Internal medicine; Interferon beta; Interferon beta-1a; Oncology; Immunology; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04181689,0.001735111,0.003788156,0.001180943,0.0003610957,0.001440827,0.00150926,0.001646533,0.002929926],"category_scores_gemma":[0.04849413,0.0009351341,0.0231823,0.0009415246,0.0004936396,0.001221996,0.00132684,0.002719436,0.0002128963],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007703581,"about_ca_system_score_gemma":0.0007421527,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002093267,"about_ca_topic_score_gemma":0.002485967,"domain_scores_codex":[0.9680763,0.02637632,0.00170084,0.00197729,0.001174216,0.0006950354],"domain_scores_gemma":[0.9420169,0.04459873,0.004293181,0.007483844,0.001049086,0.0005581762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.5086226,0.0008202891,0.07465631,0.004017813,0.3511272,0.001043935,0.0003576641,0.02566592,0.003865837,0.001525175,0.003266701,0.02503057],"study_design_scores_gemma":[0.07551967,0.03715228,0.259356,0.0007804884,0.4984878,0.001567511,0.0005309968,0.09886766,0.006353737,0.01029992,0.01048742,0.0005964675],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9535292,0.02762211,0.008827785,0.000548498,0.0005085228,0.001355515,0.005107868,0.0001788935,0.002321537],"genre_scores_gemma":[0.9935564,0.0008043589,0.002063939,0.0002390397,0.0001251557,0.0007555576,0.001810771,0.00003880854,0.0006059516],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04181689,"threshold_uncertainty_score":0.2211515,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05895747214551115,"score_gpt":0.3254030765250458,"score_spread":0.2664456043795346,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}